Matt Tyler

26 Jun, 2025

Matt is an MBA-qualified Commercial Professional, with over 17 years of experience working in the pharmaceutical and medical device space on technical operations, sales, and business management.

He understands the unique set of challenges clients face when it comes to commercial viability, product status, technical requirements, regulatory position, and growth potential.

He strives to generate sales aligned to company growth through the development of strong, long-term relationships with new and existing customers.

Other Related Articles

Blog Pharmaceutical

The Most Expensive Mistakes in Biotech Are Often Regulatory, Not Scientific

20 Aug, 2026

Blog Medical Devices

Optimizing Systematic Literature Reviews for CERs: Common Deficiencies and How to Avoid Them

20 Aug, 2026

Blog Pharmaceutical

M4Q(R2) Transition Readiness: Migrating CMC Content for the Structured Submissions of Tomorrow

19 Aug, 2026

Blog Medical Devices

Notified Body Opinion (NBOp) for Combination Products: Navigating Article 117 of the EU MDR

19 Aug, 2026

Blog Medical Devices

Received a Notified Body Deficiency Letter for Your CER? Here’s What to Do Next

13 Aug, 2026

Blog Medical Devices

Are Your CERs Audit Ready? 10 Warning Signs Before Your Next Notified Body Review

13 Aug, 2026

Blog Pharmaceutical

Technology Transfer in Pharma: Best Practices for Successful CMC and Regulatory Compliance

06 Aug, 2026

Blog Medical Devices

Drug-Device Combination Products: Is Your Device Strategy Keeping Pace with Your Drug Development?

06 Aug, 2026

View All